
I Mon 500mg/500mg Injection
Marketer
Capri Pharmaceuticals
Salt Composition
Imipenem (500mg) + Cilastatin (500mg)
Overview I Mon 500mg/500mg Injection
This dual-antibiotic injection, I Mon 500mg/500mg, combats severe bacterial infections. Administered only by a healthcare provider, it targets infectious microorganisms to prevent their spread. Consistent adherence to the prescribed dosage is crucial; complete the entire course, even with symptom improvement. Potential side effects include nausea, vomiting, diarrhea, and skin rashes; injection site reactions (redness, swelling, pain) may also occur, usually resolving spontaneously. Severe side effects or allergic reactions (rash, itching, swelling, breathing difficulty) necessitate immediate medical attention. Inform your physician of all other medications, including those for pre-existing conditions, before using this injection. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing, refrain from driving if drowsiness or dizziness occurs.
Primary Ingredients of I Mon 500mg/500mg Injection
No information provided. A rephrased version cannot be created.
Uses of I Mon 500mg/500mg Injection
Life-threatening bacterial infections
Major Benefits of I Mon 500mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of I Mon 500mg/500mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Rash
How to use I Mon 500mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How I Mon 500mg/500mg Injection works:
I Mon 500mg/500mg injection contains imipenem, an antibiotic, and cilastatin, a dehydropeptidase I inhibitor. Imipenem combats bacterial infections by disrupting the synthesis of their protective cell wall, a crucial structure for bacterial survival. Cilastatin safeguards imipenem's efficacy by inhibiting dehydropeptidase I, an enzyme that would otherwise rapidly metabolize and inactivate the antibiotic, thus extending its therapeutic presence within the body.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside I Mon 500mg/500mg Injection lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of I Mon 500mg/500mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of I Mon 500mg/500mg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingUNSAFE
Administering I Mon 500mg/500mg Injection might induce adverse reactions impacting driving capabilities. Certain side effects, including hallucinations (visual, auditory, or sensory), can impair some individuals' ability to operate a vehicle.
KidneyCAUTION
Individuals with impaired kidney function should use I Mon 500mg/500mg Injection cautiously. Dosage modification for I Mon 500mg/500mg Injection might be necessary. A physician's advice is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of I Mon 500mg/500mg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take I Mon 500mg/500mg Injection :
Omit a dose of I Mon 500mg/500mg Injection? Seek your physician's advice.
Facts to Know About I Mon 500mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
